创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

铁死亡纳米制剂在肿瘤治疗应用中的研究进展

Advances of Nano-preparations for the Treatment of Ferroptosis in Tumors

  • 摘要: 作为一种新型肿瘤治疗药物,铁死亡纳米制剂利用脂质过氧化物过量累积导致氧化还原失衡,从而引发细胞死亡的机制发挥肿瘤治疗作用。大量研究表明,铁死亡与肿瘤的发生、发展密切相关。近年来随着纳米技术的蓬勃发展,包括纳米氧化铁、无定形纳米粒、铁有机框架材料等在内的多功能纳米材料具有清除谷胱甘肽,生成过氧化氢以及催化芬顿反应等作用,并能够协同铁死亡诱导剂更好地发挥抗肿瘤作用。概述铁死亡的发生机制以及与癌症的关系,阐述铁死亡纳米制剂抗肿瘤治疗的机制,并重点综述包括铁死亡纳米制剂与传统疗法的联合治疗应用,最后展望铁死亡纳米制剂应用于肿瘤治疗的期望与挑战。

     

    Abstract: Ferroptosis as a brand-new iron-dependent use of lipid peroxide excessive accumulation leading to redox imbalance of cell death, as new tumor treatment, has attracted wide attention of researchers. Studies have shown that ferroptosis is closely related to the occurrence and development of tumors. With the development of nanotechnology in recent years, multifunctional nanomaterials such as nano-iron oxide, amorphous nanoparticles and organic iron frame can remove glutathione, produce hydrogen peroxide and catalyze Fenton reaction, so they can cooperate with ferroptosis inducers to play a better anti-tumor role. This article summarizes the mechanism of iron death and its relationship with cancer, and introduces the mechanism of iron death nano-preparation anti-tumor therapy. Then, it focuses on the application of iron death nanotechnology in cancer, including the combined treatment of iron death nano-preparations and traditional therapies. Finally, the prospects and challenges of iron death nano-preparations applied to tumor treatment are presented.

     

/

返回文章
返回